1. Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1.
- Author
-
Pang, Juan, Raka, Fitore, Heirali, Alya Abbas, Shao, Weijuan, Liu, Dinghui, Gu, Jianqiu, Feng, Jia Nuo, Mineo, Chieko, Shaul, Philip W., Qian, Xiaoxian, Coburn, Bryan, Adeli, Khosrow, Ling, Wenhua, and Jin, Tianru
- Subjects
RESVERATROL ,CHYLOMICRONS ,HOMEOSTASIS ,SECRETION ,INTESTINES ,CHENODEOXYCHOLIC acid ,HIGH-fat diet - Abstract
Two common features of dietary polyphenols have hampered our mechanistic understanding of their beneficial effects for decades: targeting multiple organs and extremely low bioavailability. We show here that resveratrol intervention (REV-I) in high-fat diet (HFD)-challenged male mice inhibits chylomicron secretion, associated with reduced expression of jejunal but not hepatic scavenger receptor class B type 1 (SR-B1). Intestinal mucosa-specific SR-B1
-/- mice on HFD-challenge exhibit improved lipid homeostasis but show virtually no further response to REV-I. SR-B1 expression in Caco-2 cells cannot be repressed by pure resveratrol compound while fecal-microbiota transplantation from mice on REV-I suppresses jejunal SR-B1 in recipient mice. REV-I reduces fecal levels of bile acids and activity of fecal bile-salt hydrolase. In Caco-2 cells, chenodeoxycholic acid treatment stimulates both FXR and SR-B1. We conclude that gut microbiome is the primary target of REV-I, and REV-I improves lipid homeostasis at least partially via attenuating FXR-stimulated gut SR-B1 elevation. Resveratrol intervention improves lipid homeostasis, but how it can target multiple organs with very low bioavailability remains elusive. Here, the authors report that gut microbiota-bile acids are linked to the hypolipidemic effect of resveratrol via inhibiting the intestinal FXR/SR-B1 signalling pathway. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF